Neurology

Two FDA Panel Members Resign Over Alzheimer's Drug Approval Two members of an FDA advisory panel have now resigned following the agency's approval of the controversial Alzheimer's drug aducanumab.
News, June 09, 2021
Time Is of the Essence: DST Up for Debate Again Seasonal time change is now up for consideration in the U.S. Congress, prompting sleep medicine specialists to weigh in on the health impact of a major policy change.
News, March 25, 2021
Late-Window Stroke Thrombolysis Not Linked to Clot Migration The results provide some reassurance that use of bridging thrombolysis before endovascular therapy will not put clots out of reach in patients who present outside the 4.5-hour window.
News, February 24, 2021
COVID-19 Linked to Large Vessel Stroke in Young Adults Physicians on the front lines of treating COVID-19 are seeing large vessel strokes in people under age 50 hospitalized with COVID-19.
News, April 24, 2020
Angiotensin Drugs and COVID-19: More Reassuring Data Data from one Wuhan hospital show no difference in COVID-19 severity or mortality in patients with hypertension taking ACE inhibitors or ARBs. Other reassuring studies are also emerging.
News, April 23, 2020
Longevity Gene Linked to Reduced AD Risk in APOE4 Carriers The klotho gene represents an exciting 'new pathway' for Alzheimer's research, a new study suggests.
News, April 20, 2020
Sleep in the Time of COVID-19 The current reality of most people's lives during the COVID-19 pandemic has the potential to induce or exacerbate sleep problems, but it may present some with ways to improve sleep, researchers say.
News, April 17, 2020
COVID-19: First Data Confirm Neurologic Symptoms Common Anecdotal reports suggest COVID-19 may cause neurologic symptoms. A new study supports these observations.
News, April 16, 2020
'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19 Marked coagulopathy and presence of antiphospholipid antibodies and cerebral infarcts in patients with COVID-19 suggest the infection represents a 'hypercoagulable' state, experts write.
News, April 14, 2020
New Guideline to Improve Ménière's Disease Diagnosis, Treatment A new clinical practice guideline provides evidence-based recommendations for diagnosing and treating Ménière's disease, along with a warning about the 'great mimicker,' vestibular migraine.
News, April 14, 2020
Both Doubts and Hope for Stents in Lipid-Rich Culprit Lesions Drug-eluting stent PCI of lipid-rich plaques by spectroscopic imaging did not adversely affect outcomes in the COLOR registry, researchers say. An editorialist said: 'The results were not favorable.'
News, April 13, 2020
Strong Support for Amyloid as Dementia Prevention Target The first published data from the 'A4' trial show strong support for amyloid as an Alzheimer's prevention target.
News, April 08, 2020
Alert FDA Updates Pregnancy Information on Interferon-β Drug Labels Updated labels state that studies have not identified a drug-associated risk of major birth defects when interferon beta products are used in early pregnancy.
News, April 06, 2020
Position Statement Tackles Sleep to Prevent Physician Burnout The American Academy of Sleep Medicine calls for research on the role of sleep in physician well-being and burnout, with the aim of finding ways to promote healthy sleep among physicians.
News, April 06, 2020
Neurologic Symptoms and COVID-19: What's Known, What Isn't Some patients with COVID-19 are also presenting with neurologic disorders, including encephalopathy, stroke, Guillain-Barre syndrome and more. What it means, however, is at this point unclear.
News, April 05, 2020
Acute Stroke Care During COVID-19: AHA's Emergency Strategy Suspending the usual review and evidence requirements for official statements, the AHA/ASA issues emergency guidance on treatment of acute stroke during the COVID-19 pandemic.
News, April 02, 2020
COVID-19: Telemedicine Gets Real, Real Fast Across Neurology In the face of COVID-19, neurologists working in stroke, epilepsy, dementia, and other subspecialties are tasked with a quick pivot from in-office patient visits to a new era of online consultations.
News, March 28, 2020
More Evidence Points to Acupuncture's Benefit for Migraine Although research has shown little difference between manual and sham acupuncture, use of a nonpenetrating sham intervention in acupuncture-naïve subjects could explain a new study's positive results.
News, March 27, 2020
An Aspirin a Day Does Not Keep Dementia at Bay Daily low-dose aspirin as prevention therapy takes another hit, this time for not reducing risk of Alzheimer's disease or cognitive impairment in a large randomized study.
News, March 27, 2020
COVID-19 and Angiotensin Drugs: Help or Harm? The controversy about whether ACE inhibitors and angiotensin blockers may affect COVID-19 infection continues, with hypotheses suggesting these drugs may both help or harm the situation.
News, March 25, 2020

No Results